This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
August 21, 2012, 08:00 am ET
Tony Tian – Investor Relations Manager
Jianyu Yang – Chairman, CEO
Adam Sun – CFO
Isabella Hau – Morgan Stanley
Sean Wu – JPMorgan
(Mital Kraus) – Private Investor
Hello and thank you for standing by the Concord Medical second quarter 2012 earnings conference call. At this time, all participants are in listen-only mode. After management's prepared remarks, there will be a question-and-answer session. Today's conference is being recorded. If you have any objections, you may disconnect at this time.
I would now like to turn the meeting over to your host for today's conference, Tony Tian, Investor Relations Manager of Concord Medical. Mr. Tian, you may begin.
Thanks. Hello, everyone, and welcome to Concord Medical's secdon quarter 2012 earnings conference call. Concord Medical's earnings release was distributed earlier today and you can find a copy on our website as well as on News Wire Services.
Today, you will hear from Dr. Jianyu Yang, Concord Medical's Chairman and CEO, and Mr. Adam Sun, Chief Financial Officer.
After their prepared remarks, Jianyu Yang and Mr. Sun will be available to answer your questions. Before we continue, please note that the discussion today will contain forward-looking statements made under the Safe Harbor provisions of the US Private Securities Litigation Reform Act of 1995 and within the meaning of Section 21E of the Securities Exchange Act of 1934 as amended.
Forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from our current expectations. Potential risks and uncertainties include but are not limited to t hose outlined in our public findings with the SEC.